Sponsors

Medical devices and IVDs – the dawn of the UK regulatory age

The UK is currently in the midst of ongoing changes to the regulation of medical devices and IVDs, with significant potential impact on pathology professionals. This is a complex overhaul with different aspects being introduced over the coming years. The next step in this process has now been communicated and it’s changed things up, explains BIVDA’s Ashleigh Batchen.

On 28 April, the Department of Health and Social Care laid a new statutory instrument in Parliament amending the current UK Medical Device Regulations 2002.1 This document has been laid in both the House of Commons and the House of Lords and will undergo a debate in each house. If these debates are successful, the statutory instrument will achieve royal assent and come into force on 30 June 2023 (as stated in the draft legislation). 

This is one of multiple legal texts expected to make up the new UKCA regulatory structure, with the following statutory instruments expected over the next year. It is crucial that the momentum provided by this publication is maximised, and there is not a major delay in laying the outstanding pieces of legislation. 

What does this change?

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026